Macrophage-specific chemotactic lipid release by in vivo streptozocin-administered mouse islets.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 1834501)

Published in Diabetes on November 01, 1991

Authors

A Muir1, B H Rovin, P E Lacy, G F Schreiner

Author Affiliations

1: Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Articles by these authors

(truncated to the top 100)

Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63

Automated method for isolation of human pancreatic islets. Diabetes (1988) 8.23

New hypothesis of insulin secretion. Nature (1968) 4.33

Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18

Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14

A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02

Altered patterns of gene expression in response to myocardial infarction. Circ Res (2000) 2.76

Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol (2000) 2.25

Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18

Automated islet isolation from human pancreas. Diabetes (1989) 2.13

The use of ficoll in the preparation of viable islets of langerhans from the rat pancreas. Transplantation (1973) 2.09

Transplantation of intact pancreatic islets in rats. Surgery (1972) 2.05

Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin. Diabetes (1972) 2.01

Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia (1973) 1.98

Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation (1991) 1.98

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A (1989) 1.83

Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration. J Immunol (1975) 1.82

Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science (1979) 1.82

Calcium-sensitive modulation of Ig capping: evidence supporting a cytoplasmic control of ligand-receptor complexes. J Exp Med (1976) 1.75

Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75

Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology (1993) 1.73

Characterization of resident glomerular cells in the rat expressing Ia determinants and manifesting genetically restricted interactions with lymphocytes. J Clin Invest (1981) 1.72

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72

64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70

Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release. J Immunol (1998) 1.67

Isolation and properties of secretory granules from rat islets of Langerhans. I. Isolation of a secretory granule fraction. J Cell Biol (1969) 1.66

The stimulus-secretion coupling of glucose-induced insulin release. V. The participation of a microtubular-microfilamentous system. Diabetes (1971) 1.66

Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J Clin Invest (1988) 1.60

Trophic factors from pancreatic islets in combined hepatocyte-islet allografts enhance hepatocellular survival. Surgery (1989) 1.59

The pancreatic beta cell. Structure and function. N Engl J Med (1967) 1.59

Chemotaxis of rat lymphocytes. J Immunol (1977) 1.53

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52

Beta granule formation in isolated islets of langerhans: a study by electron microscopic radioautography. J Cell Biol (1969) 1.51

A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48

The disruption of immunoglobulin caps by local anesthetics. Clin Immunol Immunopathol (1976) 1.46

Isolation and properties of secretory granules from rat islets of Langerhans. II. Ultrastructure of the beta granule. J Cell Biol (1969) 1.45

Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature (1973) 1.42

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40

A morphologic study of intrahepatic portal-vein islet isografts. Diabetes (1977) 1.36

Spontaneous redistribution of surface immunoglobulin in the motile B lymphocyte. J Exp Med (1976) 1.31

Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol (1999) 1.28

Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc Natl Acad Sci U S A (1989) 1.27

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol (2001) 1.27

Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest (1984) 1.27

Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest (1984) 1.26

Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res (1990) 1.26

Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens. J Exp Med (1980) 1.23

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23

Induction of rejection of successful allografts of rat islets by donor peritoneal exudate cells. Transplantation (1979) 1.22

Insulin secretion by isolated islets in presence of glucose, insulin and anti-insulin serum. Proc Soc Exp Biol Med (1967) 1.21

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18

Prolongation of islet xenograft survival without continuous immunosuppression. Science (1980) 1.18

Alloxan uptake by isolated rat islets of Langerhans. Endocrinology (1978) 1.13

Standardization fo a digestion-filtration method for isolation of pancreatic islets. Diabetes (1976) 1.11

Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci U S A (1987) 1.10

5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10

Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol (1993) 1.09

Secretion of various endocrine substances by ACTH-secreting tumors--gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon. Cancer (1968) 1.08

Insulin and glucagon secretion from rat islets maintained in a tissue culture-perifusion system. Diabetes (1979) 1.07

Isolation and properties of secretory granules from rat islets of Langerhans. 3. Studies of the stability of the isolated beta granules. J Cell Biol (1969) 1.07

Macrophages and renal disease. Lab Invest (1994) 1.07

Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro. Diabetes (1974) 1.06

Appendix: Electron miscroscopy of islets Of langerhans in rabbit pancreas slices incubated in vitro. Biochem J (1967) 1.06

The modulation of spontaneous and anti-Ig-stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents. J Immunol (1975) 1.06

Capping and the lymphocyte: models for membrane reorganization. J Immunol (1977) 1.05

Localization of an Ia-bearing glomerular cell in the mesangium. J Cell Biol (1982) 1.05

Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia (2006) 1.04

Immune mechanisms of cardiac disease. N Engl J Med (1994) 1.04

Renal subcapsular transplantation of clusters of hepatocytes in conjunction with pancreatic islets. Transplantation (1988) 1.03

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03

Endocrine secretory mechanisms. A review. Am J Pathol (1975) 1.03

Comparison of the properties of active Ca2+ transport by the islet-cell endoplasmic reticulum and plasma membrane. Biochim Biophys Acta (1983) 1.03

Alveolar soft-part sarcoma--A malignant angioreninoma: Histochemical, immunocytochemical, and electron-microscopic study of four cases. Am J Surg Pathol (1982) 1.02

Transplantation of islets of Langerhans in diabetic rhesus monkeys. Surgery (1975) 1.02

Active suppression in the maintenance of pancreatic islet allografts. Transplantation (1981) 1.01

Use of reflected green light for specific identification of islets in vitro after collagenase isolation. Diabetes (1979) 1.01

Transplantation of insulin-producing tissue. Am J Med (1981) 1.00

Calmodulin-activated protein kinase activity in rat pancreatic islet cell membranes. Arch Biochem Biophys (1982) 0.99

Long-term perfusion of isolated rats islets in vitro. Diabetes (1976) 0.99

Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes (1994) 0.99

Beta cell secretion--from the standpoint of a pathobiologist. Diabetes (1970) 0.98

Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int (1997) 0.98

Cinemicrographic studies on beta granule movement in monolayer culture of islet cells. Lab Invest (1975) 0.97

Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients. Surgery (1987) 0.97

Improvement of human islet cryopreservation by a p38 MAPK inhibitor. Am J Transplant (2007) 0.97

Alloxan inhibition of a Ca2+- and calmodulin-dependent protein kinase activity in pancreatic islets. J Biol Chem (1983) 0.96

Renoprotection: one or many therapies? Kidney Int (2001) 0.96

Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon. Diabetes (1978) 0.96

Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes. Biochem Biophys Res Commun (1988) 0.95

Fc(gamma) receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte Fc(gamma)RIII. J Immunol (1997) 0.95

Active calcium uptake by islet-cell endoplasmic reticulum. J Biol Chem (1982) 0.95

Reversal of diabetes in nude mice after transplantation of fresh and 7-day-cultured (24 degrees C) human pancreatic islets. Transplantation (1988) 0.95

A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc Natl Acad Sci U S A (1992) 0.95

The ultrastructural basis for the identification of cell types in the pancreatic islets. II. Rabbit, dog and opossum. Z Zellforsch Mikrosk Anat (1965) 0.95

Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab (2006) 0.94

Transplantation of pancreatic islets. Annu Rev Immunol (1984) 0.94